Analyst Consensus ?
ConsensusBuy51 ratings
Bullish2956.9%
Neutral2039.2%
Bearish23.9%
Fifth Third Bancorp · FITB · FY2025 Q4 · Calendar Q1 2026
Fifth Third outlines merger synergies and fee-growth priorities
The supplied analysis supports a constructive but execution-dependent thesis: management sees merger synergies, payments, wealth management and deposit growth as drivers of future earnings, while integration, loan utilization and rate sensitivity remain material tests.
Reported Before market openNYSEFinancial Services
$46.74B market cap
90quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.08
Consensus $1.00
EPS surprise
+8.4%
Reported versus consensus
Reported revenue
$2.35B
Consensus $2.34B
Revenue surprise
+0.2%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+2.0%
Event window
SPY move
-2.0%
Same window
Abnormal move
+4.0%
Stock minus SPY
Volume
3.1×
Versus trailing sessions
Subsequent drift
+7.1%
Up to 20 sessions
FITBSPY benchmark
Ask FN2 about FITB FY2025 Q4
Transcript, numbers and history already loaded
Why did FITB rise 2.0% after beating EPS estimates in FY2025 Q4?What changed in FITB's guidance and outlook in FY2025 Q4?Give me the bull and bear case for FITB after FY2025 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management reported a confident quarter and raised guidance sentiment while emphasizing the completed Comerica merger, ahead-of-schedule integration, NewLine expansion and a larger Texas deposit-gathering effort.
Guidance delta
Management's guidance sentiment was raised, with the outlook centered on net interest income growth and EPS accretion.
Key takeaways
- Management described Q4 performance as strong, with profitability, fee growth and low charge-offs highlighted.
- The Comerica merger is the central execution priority, with integration described as ahead of schedule.
- NewLine payments, wealth management and middle-market lending are identified as fee and balance-sheet growth drivers.
- Deposit growth in the Southeast and planned Texas expansion are important to the growth strategy.
- The main counterweights are loan utilization, integration execution and rate sensitivity.
Management priorities
- Complete Comerica integration and legal conversion.
- Scale the NewLine payments platform and associated fee revenue.
- Expand middle-market lending and innovation banking.
- Build Texas de novo branches and acquire retail deposits.
- Continue digital and direct-mail marketing to grow consumer households.
Follow FITB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$50.66Current
$4.5Low
$50.91Average
$67High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Sep 23, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Sep 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 21, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 20, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 20, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 20, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| UBS | Buy | Buy | Maintain | Jul 7, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 6, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 29, 2026 |
| Baird | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Mar 30, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 3, 2026 |
| Stephens & Co. | Overweight | Equal Weight | Upgrade | Oct 14, 2025 |
| Argus Research | Buy | Buy | Maintain | Jul 22, 2024 |
| Jefferies | Buy | Buy | Maintain | Jul 3, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | May 31, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 18, 2023 |
| Wedbush | Outperform | Outperform | Maintain | Jul 21, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Sep 12, 2022 |
| CFRA | Buy | Buy | Maintain | Apr 22, 2020 |
| Nomura | Neutral | Neutral | Maintain | Apr 7, 2020 |
| Odeon Capital | Hold | Hold | Maintain | Dec 6, 2019 |
| Raymond James | Outperform | Outperform | Maintain | Oct 23, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 23, 2019 |
| BMO Capital | Market Perform | Market Perform | Maintain | Apr 25, 2019 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Apr 4, 2019 |
| Argus | Buy | Buy | Maintain | Jun 14, 2018 |
| Macquarie | Underperform | Neutral | Downgrade | Nov 17, 2017 |
| Compass Point | Buy | Neutral | Upgrade | Mar 29, 2017 |
| Hilliard Lyons | Neutral | Underperform | Upgrade | Jan 25, 2017 |
| Bernstein | Market Perform | Outperform | Downgrade | Nov 16, 2016 |
| CLSA | Outperform | Outperform | Maintain | Sep 23, 2016 |
| Oppenheimer | Perform | Outperform | Downgrade | Jul 6, 2016 |
| Susquehanna | Neutral | Positive | Downgrade | Jun 7, 2016 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Apr 6, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Apr 6, 2016 |
| Credit Suisse | Underperform | Underperform | Maintain | Mar 10, 2016 |
| PiperJaffray | Neutral | Neutral | Maintain | Nov 23, 2015 |
| Guggenheim | Neutral | Buy | Downgrade | Oct 21, 2015 |
| SunTrust Robinson Humphrey | Neutral | Neutral | Maintain | Jun 29, 2015 |
| FBR Capital | Market Perform | Outperform | Downgrade | Jan 22, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Dec 16, 2013 |
| Rafferty Capital | Hold | Buy | Downgrade | Nov 6, 2013 |
| Rafferty | Hold | Buy | Downgrade | Nov 6, 2013 |
| ISI Group | Buy | Buy | Maintain | Oct 7, 2013 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Feb 11, 2013 |
| Stifel | Hold | Buy | Downgrade | Feb 11, 2013 |
| Miller Tabak | Strong Buy | Strong Buy | Maintain | Aug 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $50.66. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $63 | $52.76 | +24.3% | Sep 23, 2026 |
| D.A. Davidson | Analyst unavailable | $65 | $57.96 | +28.3% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $62 | $58.01 | +22.4% | Jul 20, 2026 |
| UBS | Erika Najarian | $65 | $58.27 | +28.3% | Jul 7, 2026 |
| Evercore ISI | Analyst unavailable | $60 | $57.72 | +18.4% | Jul 6, 2026 |
| Wells Fargo | Analyst unavailable | $67 | $57.16 | +32.2% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $58 | $52.01 | +14.5% | Jun 8, 2026 |
| Truist Financial | Analyst unavailable | $57 | $51.05 | +12.5% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $53 | $51.68 | +4.6% | Apr 21, 2026 |
| Barclays | Jason Goldberg | $63 | $50.34 | +24.3% | Apr 20, 2026 |
| Evercore ISI | Analyst unavailable | $57 | $53.48 | +12.5% | Feb 5, 2026 |
| UBS | Erika Najarian | $59 | $54.57 | +16.5% | Feb 4, 2026 |
| Truist Financial | Analyst unavailable | $60 | $50.23 | +18.4% | Jan 26, 2026 |
| D.A. Davidson | Peter Winter | $58 | $50.19 | +14.5% | Jan 26, 2026 |
| RBC Capital | Analyst unavailable | $57 | $51.62 | +12.5% | Jan 21, 2026 |
| Wolfe Research | Analyst unavailable | $55 | $49.1 | +8.6% | Jan 7, 2026 |
| Evercore ISI | John Pancari | $52 | $49.46 | +2.6% | Jan 6, 2026 |
| UBS | Analyst unavailable | $57 | $48.62 | +12.5% | Jan 6, 2026 |
| Barclays | Analyst unavailable | $61 | $47.71 | +20.4% | Jan 5, 2026 |
| Truist Financial | Brian Foran | $55 | $48.1 | +8.6% | Dec 22, 2025 |
| Piper Sandler | Analyst unavailable | $50 | $45.17 | -1.3% | Dec 10, 2025 |
| Stephens | Analyst unavailable | $52 | $42.2 | +2.6% | Oct 14, 2025 |
| D.A. Davidson | Analyst unavailable | $52 | $44.03 | +2.6% | Oct 8, 2025 |
| UBS | Analyst unavailable | $45 | $43.67 | -11.2% | Oct 7, 2025 |
| Morgan Stanley | Manan Gosalia | $60 | $43.79 | +18.4% | Oct 7, 2025 |
| Evercore ISI | Analyst unavailable | $49 | $45.4 | -3.3% | Sep 30, 2025 |
| Morgan Stanley | Manan Gosalia | $56 | $45.43 | +10.5% | Sep 29, 2025 |
| D.A. Davidson | Peter Winter | $47 | $39.58 | -7.2% | Jun 9, 2025 |
| D.A. Davidson | Peter Winter | $46 | $43.37 | -9.2% | Oct 21, 2024 |
| Citigroup | Keith Horowitz | $43 | $44.67 | -15.1% | Oct 21, 2024 |
| Piper Sandler | Scott Siefers | $48 | $41.76 | -5.3% | Oct 3, 2024 |
| Stephens | Terry McEvoy | $42 | $39.8 | -17.1% | Sep 11, 2024 |
| Piper Sandler | Scott Siefers | $45 | $42.34 | -11.2% | Sep 3, 2024 |
| Argus Research | Stephen Biggar | $46 | $40.42 | -9.2% | Jul 22, 2024 |
| RBC Capital | Gerard Cassidy | $43 | $40.99 | -15.1% | Jul 22, 2024 |
| D.A. Davidson | Peter Winter | $42 | $40.99 | -17.1% | Jul 22, 2024 |
| Wells Fargo | Mike Mayo | $42 | $35.28 | -17.1% | Jun 12, 2024 |
| Wolfe Research | Bill Carcache | $43 | $36.75 | -15.1% | May 31, 2024 |
| UBS | Erika Najarian | $39 | $36.05 | -23.0% | Apr 4, 2024 |
| Robert W. Baird | David George | $32 | $37.21 | -36.8% | Apr 1, 2024 |
| Stephens | Terry McEvoy | $41 | $35.43 | -19.1% | Mar 19, 2024 |
| Raymond James | David Long | $4.5 | $51.41 | -91.1% | Jan 19, 2024 |
| Barclays | Analyst unavailable | $47 | $32.81 | -7.2% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $36 | $31.94 | -28.9% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $37 | $33.28 | -27.0% | Dec 5, 2022 |
| Morgan Stanley | Analyst unavailable | $43 | $33.96 | -15.1% | Jul 12, 2022 |
| UBS | Erika Najarian | $56 | $48.88 | +10.5% | Jan 12, 2022 |
| Barclays | Jason Goldberg | $53 | $44.38 | +4.6% | Jan 3, 2022 |
| Argus Research | Stephen Biggar | $49 | $44.98 | -3.3% | Oct 20, 2021 |
| Stephens | Terry McEvoy | $48 | $44.98 | -5.3% | Oct 20, 2021 |
| KBW | David Konrad | $42 | $36.57 | -17.1% | Jul 6, 2021 |
Track every rating change on FITB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFifth Third Bancorp operates as the bank holding company for Fifth Third Bank, National Association that provides a range of financial products and services in the United States. It operates through three segments: Commercial Banking, Consumer and Small Business Banking, and Wealth and Asset Management. The Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and cash management, foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers.…
Historical context
All FITB earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
Get the FITB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-29T14:51:01.546669+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T14:51:01.543906+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.